US Pre-Market Brief | 2026-10-09 (ET) Friday

Coverage window: 2026-10-08 (Thu) 16:00 ET regular close → 2026-10-09 (Fri) ~08:30 ET pre-market (quote snapshots as of 07:53–08:30 ET; pre-market liquidity is thin, individual stock moves are as of the timestamps noted in the text). Thursday backdrop: AI-narrative repricing dragged tech lower for a second straight day — S&P 7,765.36 (−0.47%), Dow 51,231.64 (+0.10%), Nasdaq 27,193.34 (−1.25%); Brent broke above $105 intraday before settling at $103.87 (+3.66%), the 10Y yield fell back to 5.23%, VIX 15.41; overnight reports again that the White House asked the Pentagon to prepare pre-election strike options on Iran. Data sourcing: fundamentals from stockanalysis.com (SEC filings compiled by S&P Global, TTM / latest disclosed quarter; fwd P/E on a consensus basis with the 10/8 close as the denominator; gap stocks flagged separately) + company press releases and SEC 8-Ks (Delta IR, Clover IR, Alignment 8-K, official CMS fact sheet) + Barron's/MarketWatch/Yahoo and other media reports, cross-checked across sources; individual stock prices are the official 10/8 closes unless noted, with pre-market indicative prices timestamped separately (08:09 ET snapshot).

0. Today's One-Line Summary

Overnight into this morning is a dual-track session of "an oil-pullback-driven recovery day + a Medicare star-rating reshuffle": Trump said he will not strike Iran before the midterms and called talks with Tehran "constructive"; Brent fell from above $105 to ~$103.5 (−0.8%), WTI $90.9,10Y steadied at 5.23%, and stock index futures — down two straight days — bounced (Nasdaq 100 +0.7~0.8% pre-market, S&P +0.4%), with AI semis bouncing off oversold levels (NVDA/TSM +1.4%/+1.8% pre-market). The hardest single-stock event is the post-CMS-2027-Medicare-star-rating reshuffle: HUM's key contract was upgraded, Leerink estimates ~96% of members will be in 4-star+ plans in 2027 (+15% pre-market, a 52-week high), ALHC's California contract dropped to 3.5 stars (−23%, a new low), and CLOV's PPO plan earned 5 stars (+11%). On the bearish side: DAL's pre-market Q3 print missed for the first time in two years and cut full-year EPS guidance from $6.50–7.50 to $5.10–5.60 (fuel cost +62% YoY), yet the stock is only −1.5% pre-market, showing the bad news was already telegraphed by this week's string of investment-bank downgrades. Driver types: regulatory disclosure (S) + earnings/guidance (A) + geopolitics (A). Today's calendar is empty (only 8:30 import prices); with big-bank earnings next Tuesday and the 10/14 CPI ahead, this looks more like a sentiment-repair window than the start of a new trend.

1. News Overview

Tiering note: news-impact tiers use S/A/A-/B+/B/C (including event-level A-), while the stock-level bullish tiers in Section 3 (S/A+/A/B+/B/C) are a separate scale — the two do not map to each other.

⚠️ Data-fetch failure note: this machine's yfinance channel returned YFRateLimitError (HTTP 429) for all 12 candidate stocks today (quoteSummary/chart/fast_info), still failing after 3 rounds of retries → all fundamentals and price data were pulled via the backup channel stockanalysis.com instead (scraped 07:53–08:30 ET, with the batch fundamentals snapshot 07:53–08:09), cross-checked as usual; conclusions unaffected.

• One methodology conflict was corrected per actual readings: some media this morning (05:30–06:30 ET snapshots) reported DAL pre-market "−4% to ~$79"; the 08:09 ET actual snapshot was −1.46% @$80.94, and this report uses the latter, with timestamps noted in the text.
• Not obtained: contract-level detail from the CMS 2027 ratings for HUM/ALHC/CLOV (relying on Barron's/Leerink paraphrase and company announcements); ELV pre-market quote (not on the movers list, judged quiet); some India/Asia-Pacific indices mixed intraday vs closing figures (the text uses directional language only).

2. Strongest Themes, Ranked

3. Stock Strength Leaderboard

Basis: the bullish zone is sorted by total score; the bearish zone is listed separately (the total reflects event strength, not buy value — the label is the conclusion). The scoring model (positive max 95 + risk deduction) is in Section 4.

4. Stock Scoring Model (positive max 95 + risk deduction 0~−15)

Model: source authority 0–15 | catalyst directness 0–20 | earnings elasticity 0–15 | moat & fundamentals 0–15 | expectation gap 0–10 | catalyst durability 0–10 | trading profile 0–10; the positive total maxes at 95; risk deduction 0~−15. Note: all fwd P/E figures in the tables are on the 10/8 close basis (stockanalysis consensus); gap stocks were recalculated at pre-market prices and flagged in the text.

• HUM 76 = 14 + 19 + 13 + 12 + 6 + 9 + 9 − 6. CMS official disclosure + mainstream financial media coverage (14); the upgrade directly determines the 2027 quality bonus (19); 2026 EPS was held to a low base by the star ratings, so the bonus's return carries big elasticity (13); one of two MA giants at scale + net cash (12); +15% pre-market partly prices it in (6); payment year 2027 locked (9); large-cap liquidity (9); deductions: gap open and valuation jump (−6).
• TSM 58 = 8 + 6 + 13 + 15 + 4 + 6 + 10 − 4.
• NVDA 56 = 8 + 6 + 13 + 15 + 4 + 5 + 10 − 5.
• CLOV 54 = 13 + 17 + 10 + 4 + 5 + 8 + 4 − 7.
• XOM 52 = 8 + 6 + 9 + 12 + 4 + 7 + 9 − 3; CVX 51 = 8 + 6 + 9 + 12 + 4 + 7 + 9 − 4.
• UNH 48 = 8 + 5 + 5 + 13 + 4 + 6 + 9 − 2; PEP 48 = 9 + 4 + 4 + 12 + 5 + 7 + 9 − 2.
• DAL (bearish basis) 49 = 15 + 20 + 2 + 9 + 4 + 5 + 9 − 15 (risk deduction maxed: guidance cut 24%, fuel exposure, call risk). The total is high but the direction is empty — conclusion = avoid.
• ALHC (bearish basis) 44 = 13 + 18 + 3 + 6 + 3 + 7 + 6 − 12. AAL 30 = 8 + 8 + 2 + 5 + 3 + 5 + 7 − 8.

5. Top Stock Deep Dives (Top 10)

HUM (Humana) — Priority deep-dive (don't chase the gap, wait for the pullback)

• Related news: CMS released the 2027 MA star ratings this week (data leaking from 10/4, official fact sheet 10/8); Barron's/IBD reported this morning that Humana's key MA plan was upgraded, with Leerink estimating ~96% of members in 4-star+ plans in 2027 (only about 20% in 2026; 42% under some estimation approaches) (Barron's⁸). Pre-market +15.36% $446.60 (08:09), breaking above the 52-week high $428.88 to set a new 52-week high.
• Catalyst logic: Not earnings — it's a regulatory pricing re-rating: the 4-star line is the quality-bonus (QBP) threshold; crossing it means the 2027 bonus + better member retention flow straight into EPS. Biggest impact on revenue/EPS, sentiment second.
• Theme and stage: healthcare quality re-rating, day one; the ratings came out this week and the market is concentrating its reaction this morning — re-pricing can continue after the open.
• Fundamentals check (stockanalysis, TTM / latest disclosed quarter): Q2'26 revenue $40,867M (+26.2%); OPM only 2.3% (managed-care thin margins); net cash $7.9B (total debt $14.7B vs cash $23.9B); FCF $1.95B; P/E (ttm) 36.6, fwd 31.2 (10/8 close basis; ~36× recalculated at the pre-market $446.6); market cap $46.5B. The factor holding down the 2026 adjusted EPS guidance of "at least $9.00" (Globe and Mail 9/11 reiteration¹⁸) is precisely the star ratings — a 2027 reversal gives direct EPS leverage.
• Moat: the second-largest MA insurer in the US; scale + hospital networks + sticky government contracts.
• Pre-market and technicals: +15% gap to a new 52-week high, no trapped overhead supply for a year above; note the HAE lesson from yesterday cuts both ways — when event hardness is extremely high the gain can hold, but large pre-market gaps historically fill, so statistically don't chase blindly; fwd P/E ~36× at the pre-market price, no longer floor-level.
• Final call: The hardest catalyst in the entire market today, S-tier. Don't chase the 9:30 open gap; validation points = volume in the first 30–60 minutes after the open and how the pullback holds at $430 (the old 52-week high). If it holds more than half the gap, trend money will take over.

DAL (达美航空 (Delta Air Lines)) — Avoid

• Related news: Q3 earnings this morning at 7:00 ET (Delta IR⁶): adjusted EPS $1.72 below the consensus $1.76 (TheFly), the first miss in two years; adjusted revenue $17.58B slightly below $17.76B; GAAP total revenue $20.2B, a record, +16% YoY (flat capacity, yield-driven); FY26 EPS guidance $5.10–5.60 (from $6.50–7.50, midpoint cut 24%), FCF cut to ~$2.5B (from $3–4B, TheFly); Q4 guidance EPS $1.15–1.65 (consensus $1.42), revenue +20%, fuel assumption $4.25/gal (including ~$0.40/gal refinery contribution, per Delta IR). Pre-market −1.46% $80.94 (08:09). CEO Bastian: demand is strong, fares are rising, and the company will absorb an extra $6 billion in fuel costs this year; on the new Saudi route, "safety calls the shots" (CNBC¹⁹, against the backdrop of Houthi attacks on Riyadh airport).
• Catalyst logic: A classic stagflation case — the cost side (fuel +62%, an extra $6 billion this year) crushing profits while demand hits records. The guidance (cut 24%) matters far more than the quarterly miss; the width of the Q4 range ($1.15–1.65) is itself the price tag of uncertainty.
• Theme and stage: fuel-inflation transmission, brewing.
• Fundamentals check: Q2'26 revenue $19,757M (+18.7%); OPM 7.8%; net debt $16.4B; FCF $3.41B; P/E (ttm) 13.6 / fwd 12.9; market cap $53.7B.
• Pre-market and technicals: the mild −1.46% reaction = the bad news was telegraphed (Bernstein/WF/BofA/Susquehanna cut PTs to $95–100 in sequence this week, all keeping Buy/Outperform ratings — see the stockanalysis DAL news roundup²⁰). 52-week range $55–95.68, the current $81 in the lower-middle.
• Final call: Avoid — neither short nor catch. Low valuation + strong demand cap the short case; unresolved fuel exposure caps the long case. Reassess if the 10:00 ET call adds new information on fuel hedging / fare pass-through. UAL/AAL pressured in sympathy, but mildly.

ALHC (Alignment Healthcare) — Avoid

• Related news: 8-K (StockTitan 10/9): California HMO contract H3815 expected at 3.5 stars for 2027 (4.0 in 2026), losing the quality bonus; the company also announced 6 of 7 eligible contracts rated ≥4 stars (MarketWatch¹⁰, GlobeNewswire²¹). Pre-market −22.96% $6.71, breaking below the 52-week low $7.37 to a new low.
• Catalyst logic: H3815 is its largest member contract; 3.5 stars = losing both the 2027 bonus and subsidies; the PR's "6/7 ≥4 stars" failed to offset, showing the market prices by member weighting.
• Theme and stage: the damaged side of the same star-rating theme; note ALHC/ELV/SCAN are suing CMS demanding a recalculation (Clover's 5/27 court win already set a court-ordered recalculation precedent) — a "lawsuit reversal" recovery option exists, but the timeline is uncontrollable.
• Fundamentals check: Q2'26 revenue $1,336M (+31.6%); OPM 1.2%; net cash $0.36B; fwd P/E 14.6 (close basis, ~11× at the pre-market price); market cap just $1.8B.
• Final call: Avoid, don't catch the falling knife. The valuation looks cheap after −23%, but the 2027 EPS base will be cut by the bonus loss — the "cheap" denominator needs a rebuild. Small-cap + new low + unresolved event = high liquidity risk. The short side is poor value too (already one-time released). Watch.

CLOV (Clover Health) — Watch only

• Related news: Company IR this morning: the 2027 MA PPO plan earns a 5-star rating; after the June court-ordered recalculation, H5141 went 3.5→4.5 stars and H8010 4.0→4.5 stars; HEDIS clinical score 4.82/5 (Clover IR¹²). Pre-market +11.35% $5.10, approaching the 52-week high $5.59.
• Catalyst logic: A 5-star contract qualifies for the maximum quality bonus + year-round special-enrollment-period inflows — a revenue-elasticity event; but the company is still in net loss (Q2 OPM −0.7%), so the theme's hardness comes from the "loss-reduction path," not profits.
• Fundamentals check: Q2'26 revenue $743M (+55.6%); net cash ~$0.2B; P/E n/a while loss-making, fwd P/E 63; market cap $2.4B; high short interest, squeeze-prone.
• Final call: The event is real and positive, but small-cap + unprofitable + near prior highs — suited only to short-horizon money with high risk tolerance; the rating is watch only. If the HUM sector move extends, CLOV has the most elasticity; conversely it falls the deepest.

TSM (台积电 (TSMC) ADR) — Watch closely

• Related news: No company news; oversold bounce +1.75% $466.00 (yesterday −3.01% to $458); the next hard checkpoint is the 10/15 monthly revenue and Q3 gross margin (whether the September revenue +54.6% YoY holds up awaits margin confirmation — see the 10-08 recap).
• Catalyst logic: Beta repair, not a new catalyst; the AI capex demand narrative (including SpaceX in talks for a $40B debt raise to buy NVDA chips, FT/WSJ 10/6–7²²) is neutral-to-bullish.
• Fundamentals check: Q2'26 revenue NT$1.27 trillion (+36.1%); OPM 56.1%; net cash $77 billion; FCF $35.8B; P/E (ttm) 29.7 / fwd 20.3; market cap $2.07T.
• Final call: A buy-the-dip opportunity. Validation = the $455–460 support band (yesterday's $458 close is already inside the band); no position-adding logic before the 10/15 gross margin. Watch closely.

NVDA (英伟达 (Nvidia)) — Watch only

• Related news: Oversold bounce +1.44% $233.79 (yesterday −2.94% to $230.48, a low after the $235 support test failed); no new hard catalyst overnight. The AI narrative re-rating still reverberates: FT reports OpenAI's annualized revenue at ~$50 billion (September basis), $20 billion below the ~$70 billion previously hinted to investors, which directly triggered Thursday's tech selloff (U.S. News/Reuters²³, CNN²⁴, 10/8 background).
• Fundamentals check: FY26Q2 revenue $96,221M (+105.9%); OPM 65.2%; net cash $23.6 billion; FCF $127B; P/E (ttm) 29.1 / fwd 19.1.
• Final call: The bounce is technical; the narrative risks (customer revenue quality, circular-dealing questions, WSJ 10/7²⁵) have no new resolution. Watch only; the $230 round number and yesterday's low are the short-term bull/bear dividing line.

UNH (联合健康 (UnitedHealth)) — Watch only

• Related news: Limited spillover from the HUM re-rating, pre-market +0.40% $372.45 (52-week range $255.97–461.62). No star-rating highlight of its own for 2027.
• Fundamentals check: Q2'26 revenue $112,032M (+0.4%); OPM 5.4%; net debt $44.7B (among the most leveraged of the MCOs); FCF $23.6B; P/E (ttm) 23.9 / fwd 17.4; market cap $333B.
• Final call: HUM's move is a "single-name re-rating," not "sector beta"; UNH has no catalyst of its own for now. Watch only; watch whether it later discloses contract-level rating details.

XOM (埃克森美孚 (ExxonMobil)) / CVX (雪佛龙 (Chevron)) — Watch only

• Related news: Oil gives back gains today (on Trump's remarks), XOM −0.69% $167.33, CVX −0.62% $210.24 (08:09, both pulling back from 52-week-high territory; 52-week highs $176.41/$217.78). Medium-term support: the EIA lifted its Q4 Brent forecast to $105 ($96 for 2026) (FinanceFeeds¹⁵).
• Fundamentals check (XOM/CVX): Q2'26 revenue +44.1%/+53.5% (the high-oil windfall); OPM 11.2%/13.0%; FCF $30.6B/$27.0B; fwd P/E 13.0/12.6.
• Final call: Yesterday's +3% surge and today's small giveback is a normal rhythm; neither chase nor short today — around $103 oil the bullish and bearish information offsets (short-term narrative cooling vs the medium-term EIA upgrade). If oil dips below $100, both become better medium-term watch names.

UAL (美联航 (United Airlines)) — Watch only

• Related news: DAL earnings read-through, pre-market −0.47% $106.94, a mild reaction.
• Fundamentals check: Q2'26 revenue $17,672M (+16.0%); OPM 7.0%; net debt $17.0B; FCF $2.54B; P/E (ttm) 10.1 / fwd 11.3.
• Final call: Fuel exposure structurally identical to DAL; wait for DAL's 10:00 call and its language on fare pass-through before picking a direction. Watch only.

6. Bearish / Avoid List

7. Intra-Theme Ranking

Theme 1: CMS 2027 MA Star Ratings (today's main line)

Theme 2: AI Compute (Repair Watch)

Theme 3: Energy (Medium-Term Logic / Short-Term Cooling)

8. Opening Validation Signals

• Pre-market (before 9:30): ① Does HUM's +15% gap gap-and-go or gap-fill — volume in the first 30 minutes and the pullback at $430 (the old 52-week high) is the discriminator; yesterday's HAE (+17% held) says "don't bet the fade when event hardness is extreme," but HUM's market cap and gap size are bigger — holding within half the gap still counts as strong; ② whether DAL's decline holds within −2% before the 10:00 call (a bigger drop says institutions aren't buying the "strong demand" line); ③ whether NDX's +0.8% bounce holds into the open (oil turning positive again would siphon it).
• Intraday: ① sector-ETF correlation — does XLV lead today (the healthcare theme), and can XLE hold its early weakness on the medium-term EIA logic; ② does the airline sector get dragged down by DAL (AAL is the sentiment amplifier); ③ volume behind the tech bounce: a bounce without volume is short covering, not a trend signal; ④ does TSM hold $455–460.
• Options sentiment: post-earnings IV crush on DAL (the event is resolved, premium sellers harvest); call skew and the volume distribution in HUM after the gap; VIX 15.4 (yesterday's close) is low — if today closes green the VIX may break below 15, so beware the pre-weekend low-vol trap.
• Risks: ① Trump already set a reversal precedent yesterday (strike options at night, walked back by day) — Middle East headlines can return anytime; ② next Monday's Columbus Day bond closure means no stock-bond cross signals, weekend position risk is yours; ③ no major data next Monday/Tuesday — if today's sentiment repair fails, the market shrinks back to watch-and-wait before next week's CPI + bank earnings.

9. Final Conclusions

① Today's 5 most noteworthy stocks

② Today's 3 strongest themes: 1) CMS 2027 MA star-rating reshuffle (core catalyst: quality-bonus payment eligibility reshuffled; durability = payment year 2027 locked; representatives: HUM/CLOV; damaged: ALHC); 2) oil-inflation transmission (core catalyst: DAL's empirical fuel +62% and the oil pullback from Trump's no-strike stance; durability = pre-midterm back-and-forth; representatives: XOM/CVX medium-term, airlines damaged); 3) AI compute oversold repair (core catalyst: risk appetite returning; durability = short-term, no new hard catalyst; representatives: NVDA/TSM).

③ Today's avoid directions: airlines (DAL's guidance cut 24% with fuel exposure unresolved; AAL the highest leverage), ALHC (downgrade + new low, the denominator needs a rebuild), AI power mapping (TLN/VST, a sourceless technical bounce). Energy stocks: don't chase today but no short either.

④ Final one-line call: Today is a repair day where "the Medicare star ratings move single stocks and the geopolitical remarks move the broad market" — HUM's +15% is the hardest event of the day but not for chasing the gap; DAL's guidance cut was telegraphed, so airlines can breathe but can't be bought; how far the broad market bounces depends on oil holding below $103; the real direction comes next week (bank earnings + CPI) — don't run full size today.

⚠️ Risk warning: this list is pre-market information sorting and observation only, and does not constitute investment advice. US stocks are volatile with high pre-market gap risk; post-earnings IV crush and guidance reversals occur; auto-generated content may carry information-timeliness gaps or factual errors — defer to company disclosures / SEC filings, and do not use this directly as a trading basis.